These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
295 related articles for article (PubMed ID: 1394190)
1. Immunization of colorectal cancer patients with modified ovine submaxillary gland mucin and adjuvants induces IgM and IgG antibodies to sialylated Tn. O'Boyle KP; Zamore R; Adluri S; Cohen A; Kemeny N; Welt S; Lloyd KO; Oettgen HF; Old LJ; Livingston PO Cancer Res; 1992 Oct; 52(20):5663-7. PubMed ID: 1394190 [TBL] [Abstract][Full Text] [Related]
2. Effects of desialylation of ovine submaxillary gland mucin (OSM) on humoral and cellular immune responses to Tn and sialylated Tn. O'Boyle KP; Coatsworth S; Anthony G; Ramirez M; Greenwald E; Kaleya R; Steinberg JJ; Dutcher JP; Wiernik PH Cancer Immun; 2006 Mar; 6():5. PubMed ID: 16524255 [TBL] [Abstract][Full Text] [Related]
3. Antibodies against mucin-associated sialyl-Tn epitopes correlate with survival of metastatic adenocarcinoma patients undergoing active specific immunotherapy with synthetic STn vaccine. MacLean GD; Reddish MA; Koganty RR; Longenecker BM J Immunother Emphasis Tumor Immunol; 1996 Jan; 19(1):59-68. PubMed ID: 8859725 [TBL] [Abstract][Full Text] [Related]
4. Anti-Tn human monoclonal antibodies generated following active immunization with partially desialylated ovine submaxillary mucin. O'Boyle KP; Wright K Hum Antibodies Hybridomas; 1994; 5(1-2):25-31. PubMed ID: 7532023 [TBL] [Abstract][Full Text] [Related]
5. Immune responses of mice and human breast cancer patients following immunization with synthetic sialyl-Tn conjugated to KLH plus detox adjuvant. Longenecker BM; Reddish M; Koganty R; MacLean GD Ann N Y Acad Sci; 1993 Aug; 690():276-91. PubMed ID: 7690215 [TBL] [Abstract][Full Text] [Related]
6. Specificity of the IgG response in mice and human breast cancer patients following immunization against synthetic sialyl-Tn, an epitope with possible functional significance in metastasis. Longenecker BM; Reddish M; Koganty R; MacLean GD Adv Exp Med Biol; 1994; 353():105-24. PubMed ID: 7527178 [TBL] [Abstract][Full Text] [Related]
7. Immune sera and monoclonal antibodies define two configurations for the sialyl Tn tumor antigen. Zhang S; Walberg LA; Ogata S; Itzkowitz SH; Koganty RR; Reddish M; Gandhi SS; Longenecker BM; Lloyd KO; Livingston PO Cancer Res; 1995 Aug; 55(15):3364-8. PubMed ID: 7614472 [TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of synthetic TF-KLH (keyhole limpet hemocyanin) and sTn-KLH conjugates in colorectal carcinoma patients. Adluri S; Helling F; Ogata S; Zhang S; Itzkowitz SH; Lloyd KO; Livingston PO Cancer Immunol Immunother; 1995 Sep; 41(3):185-92. PubMed ID: 7553688 [TBL] [Abstract][Full Text] [Related]
9. Induction of alpha-N-acetylgalactosamine-O-serine/threonine (Tn) antigen-mediated cellular immune response for active immunotherapy in mice. Singhal A; Fohn M; Hakomori S Cancer Res; 1991 Mar; 51(5):1406-11. PubMed ID: 1997178 [TBL] [Abstract][Full Text] [Related]
10. Specificity analysis of murine monoclonal antibodies reactive with Tn, sialylated Tn, T, and monosialylated (2-->6) T antigens. O'Boyle KP; Markowitz AL; Khorshidi M; Lalezari P; Longenecker BM; Lloyd KO; Welt S; Wright KE Hybridoma; 1996 Dec; 15(6):401-8. PubMed ID: 8985750 [TBL] [Abstract][Full Text] [Related]
11. Mucins bearing the cancer-associated sialosyl-Tn antigen mediate inhibition of natural killer cell cytotoxicity. Ogata S; Maimonis PJ; Itzkowitz SH Cancer Res; 1992 Sep; 52(17):4741-6. PubMed ID: 1511439 [TBL] [Abstract][Full Text] [Related]
12. Vaccines prepared with sialyl-Tn and sialyl-Tn trimers using the 4-(4-maleimidomethyl)cyclohexane-1-carboxyl hydrazide linker group result in optimal antibody titers against ovine submaxillary mucin and sialyl-Tn-positive tumor cells. Ragupathi G; Howard L; Cappello S; Koganty RR; Qiu D; Longenecker BM; Reddish MA; Lloyd KO; Livingston PO Cancer Immunol Immunother; 1999 Apr; 48(1):1-8. PubMed ID: 10235483 [TBL] [Abstract][Full Text] [Related]
13. Immunization of high-risk breast cancer patients with clustered sTn-KLH conjugate plus the immunologic adjuvant QS-21. Gilewski TA; Ragupathi G; Dickler M; Powell S; Bhuta S; Panageas K; Koganty RR; Chin-Eng J; Hudis C; Norton L; Houghton AN; Livingston PO Clin Cancer Res; 2007 May; 13(10):2977-85. PubMed ID: 17504999 [TBL] [Abstract][Full Text] [Related]
14. The significance of anti-sialyl-Tn antibodies in patients with colorectal and breast cancer. Coomber DW; Hawkins NJ; Dalley D; Ward RL Neoplasma; 1998; 45(1):12-6. PubMed ID: 9604995 [TBL] [Abstract][Full Text] [Related]
15. Enzymatic large-scale synthesis of MUC6-Tn glycoconjugates for antitumor vaccination. Freire T; Lo-Man R; Piller F; Piller V; Leclerc C; Bay S Glycobiology; 2006 May; 16(5):390-401. PubMed ID: 16449349 [TBL] [Abstract][Full Text] [Related]
16. Immunization of breast cancer patients using a synthetic sialyl-Tn glycoconjugate plus Detox adjuvant. MacLean GD; Reddish M; Koganty RR; Wong T; Gandhi S; Smolenski M; Samuel J; Nabholtz JM; Longenecker BM Cancer Immunol Immunother; 1993; 36(4):215-22. PubMed ID: 8439984 [TBL] [Abstract][Full Text] [Related]
17. The serologic response to Meth A sarcoma vaccines after cyclophosphamide treatment is additionally increased by various adjuvants. Livingston PO; Jones M; Deleo AB; Oettgen HF; Old LJ J Immunol; 1985 Aug; 135(2):1505-9. PubMed ID: 4008930 [TBL] [Abstract][Full Text] [Related]
18. SialylTn-mAb17-1A carbohydrate-protein conjugate vaccine: effect of coupling density and presentation of SialylTn. Kircheis R; Vondru P; Nechansky A; Ohler R; Loibner H; Himmler G; Mudde GC Bioconjug Chem; 2005; 16(6):1519-28. PubMed ID: 16287250 [TBL] [Abstract][Full Text] [Related]
19. Preparation and characterization of monoclonal antibodies directed to the tumor-associated O-linked sialosyl-2----6 alpha-N-acetylgalactosaminyl (sialosyl-Tn) epitope. Kjeldsen T; Clausen H; Hirohashi S; Ogawa T; Iijima H; Hakomori S Cancer Res; 1988 Apr; 48(8):2214-20. PubMed ID: 2450649 [TBL] [Abstract][Full Text] [Related]
20. An O-acetylated sialyl-Tn is involved in ovarian cancer-associated antigenicity. Toba S; Tenno M; Kurosaka A Biochem Biophys Res Commun; 2000 May; 271(2):281-6. PubMed ID: 10799288 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]